Large telecom company advances metabolic health
Company’s key priorities
Deliver cost-effective benefits while maintaining high-quality member experience
Drive sustained behavior change through high-touch clinical care teams
Ensure responsible GLP-1 prescribing and medication management
Guide employees through formulary and pharmacy transitions with clear communications
*dependent on client terms
Improving metabolic health at scale
The company launched Vida in October 2024 to provide employees and their families with a comprehensive solution.
Members receive support from physician-led, multidisciplinary care teams. Through behavior change support, medical nutrition therapy, and medication (when appropriate), Vida helps members achieve sustainable weight loss and improved metabolic health. A key focus of the program is responsible GLP-1 prescribing.
By guiding members through appropriate treatment pathways—including behavioral interventions and alternative anti-obesity medications—Vida helps Charter manage pharmacy costs while ensuring employees receive personalized, clinically appropriate care.
Telecommunication company’s results
with Vida
Clinically significant weight loss at scale, exceeding established benchmarks within 12 months
Improved glycemic control and overall disease management
Substantial improvements in mental health, including reduced symptoms of anxiety and depression
Successfully reduced risk of progressing from prediabetes to diabetes
Engagement rate exceeded Vida’s broader book of business
Members report a strong connection with their Vida provider
Company’s perspective
“Vida has been a strong partner in helping us deliver clinically guided care while managing the complexities of GLP-1 utilization and benefit transitions. Together, we’re supporting our employees with a thoughtful, sustainable approach to metabolic health.”
“Working closely with Vida allowed us to anticipate employee questions, set expectations early, and guide members through formulary and pharmacy transitions in a thoughtful way.”